Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus) - Full Text View

Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)

This study has been suspended.

Sponsored by:	National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:	NCT00065234

Purpose

The purpose of this study is to determine if acupuncture is effective in preventing prolonged postoperative paralysis of the gastrointestinal tract among patients undergoing colostomy/ileostomy closure.

Condition	Intervention	Phase
Ileus Neoplasms	Procedure: Acupuncture	Phase II

MedlinePlus related topics:

Acupuncture Cancer Paralysis

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study

Official Title:	Acupuncture to Prevent Postoperative Paralytic Ileus

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:	100
Study Start Date:	September 2003
Estimated Study Completion Date:	May 2006

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Previous surgical cancer treatment with ileostomy/colostomy, now scheduled for closure
Hospital admission must be same day as surgery

Exclusion Criteria:

Incapacitating disease
Concurrent herbal or laxative use
Use of Heparin or Coumadin
Upper or lower extremity deformities
Chronic constipation prior to cancer diagnosis
History of cerebrovascular accident or spinal cord injury
Chronic pain that has been treated with any form of major opioid or weak opioids (=/> 30mg/24 hours)
Pacemaker or metal implants
Concurrent alternative medicine/herbal use

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00065234

Locations


United States, Texas
	MD Anderson Cancer Center
	Houston, Texas, United States, 77030

Sponsors and Collaborators

National Center for Complementary and Alternative Medicine (NCCAM)

Investigators


Principal Investigator:	Joseph S Chiang, MD	M.D. Anderson Cancer Center

More Information

Study ID Numbers:	R21 AT001065-01A1, ChiangJ
First Received:	July 18, 2003
Last Updated:	August 16, 2006
ClinicalTrials.gov Identifier:	NCT00065234
Health Authority:	United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):

Colostomy

Ileostomy

Study placed in the following topic categories:

Intestinal Obstruction

Paralysis

Ileus

Digestive System Diseases

Gastrointestinal Diseases

Intestinal Diseases

Intestinal Pseudo-Obstruction

Additional relevant MeSH terms:

Neoplasms

ClinicalTrials.gov processed this record on October 17, 2008